Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new publication citation was added to the Publications section and the page revision was updated to v3.5.4, replacing the prior v3.5.3 and removing the associated Erratum note.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision/build label was updated from v3.5.2 to v3.5.3, reflecting a routine ClinicalTrials.gov interface/version change rather than a modification to the study record.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded the Drug Saf. 2021 article citation with an erratum and updated the revision label from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check71 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, reflecting a new version tag rather than content changes.SummaryDifference0.1%

- Check86 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. This change does not affect the study information or user workflows.SummaryDifference0.1%

- Check107 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are visible.SummaryDifference0.1%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.